CD276 Recombinant Protein

Reference: PX-P4125-100
Product nameCD276 Recombinant Protein
Uniprot IDQ5ZPR3
Uniprot linkhttp://www.uniprot.org/uniprot/Q5ZPR3
Origin speciesHomo sapiens (Human)
Expression systemEukaryotic expression
SequenceMLRRRGSPGMGVHVGAALGALWFCLTGALEVQVPEDPVVALVGTDATLCCSFSPEPGFSLAQLNLIWQLTDTKQLVHSFAEGQDQGSAYANRTALFPDLLAQGNASLRLQRVRVADEGSFTCFVSIRDFGSAAVSLQVAAPYSKPSMTLEPNKDLRPGDTVTITCSSYQGYPEAEVFWQDGQGVPLTGNVTTSQMANEQGLFDVHSILRVVLGANGTYSCLVRNPVLQQDAHSSVTITPQRSPTGAVEVQVPEDPVVALVGTDATLRCSFSPEPGFSLAQLNLIWQLTDTKQLVHSFTEGRDQGSAYANRTALFPDLLAQGNASLRLQRVRVADEGSFTCFVSIRDFGSAAVSLQVAAPYSKPSMTLEPNKDLRPGDTVTITCSSYRGYPEAEVFWQDGQGVPLTGNVTTSQMANEQGLFDVHSVLRVVLGANGTYSCLVRNPVLQQDAHGSVTITGQPMT
Molecular weight70kDa
Protein delivered with Tag?C-terminal His Tag
Purity estimated>95% by SDS-PAGE
BufferPBS pH7.5
Delivery conditionDry Ice
Storage conditionStore at - 20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage.
BrandProteoGenix
Host speciesMammalian cells
ApplicationsELISA,WB
Fragment TypeMet1-Thr461
Aliases /SynonymsB7H3, PSEC0249, UNQ309/PRO352
ReferencePX-P4125
NoteFor research use only

Description of CD276 Recombinant Protein

General information on CD276 Recombinant Protein:

CD276, also known as B7-H3, is a member of the B superfamily and has IgV and IgG regions in the extracellular domain. It is a type I transmembrane protein with 20-27% amino acid identity to other members of the B7 family. B7-H3 participates in the activation of T lymphocytes and regulates the formation of mouse bone. It has also been reported that B7-H3 may play an important role in muscle-immune interaction, providing further evidence for the active role of muscle cells in the local immune regulation process. B7-H3 is expressed on T cells, natural lethal cells and antigenic cells, and certain non-immune cells (such as osteoblasts, fibroblasts, fibroblast-like synovial cells, and epithelial cells). The high expression of B7-H3 in the tumor vasculature also indicates poor patient survival, indicating that it may play a role in the migration of tumor cells.

Enoblituzumab Biosimilar - Anti-CD276, B7-H3 mAb binds to CD276 Recombinant Protein in indirect ELISA Assay

Immobilized CD276 Recombinant Protein (cat. No.PX-P4125) at 0.5µg/mL (100µL/well) can bind to Enoblituzumab Biosimilar - Anti-CD276, B7-H3 mAb (cat. No.PX-TA1410) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450

Reviews

Il n’y a pas encore d’avis.

REVIEW YOUR PRODUCT

Soyez le premier à laisser votre avis sur “CD276 Recombinant Protein”

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

Related products

Enoblituzumab Biosimilar – Anti-CD276, B7-H3 mAb – Research Grade
Biosimilar

Enoblituzumab Biosimilar – Anti-CD276, B7-H3 mAb – Research Grade

PX-TA1410 400€
Omburtamab Biosimilar – Anti-CD276, B7-H3, B7RP-2 mAb – Research Grade
Biosimilar

Omburtamab Biosimilar – Anti-CD276, B7-H3, B7RP-2 mAb – Research Grade

PX-TA1532 400€
Mirzotamab  Biosimilar – Anti-CD276, B7-H3 mAb – Research Grade
Biosimilar

Mirzotamab Biosimilar – Anti-CD276, B7-H3 mAb – Research Grade

PX-TA1596 400€
Obrindatamab Biosimilar – Anti-CD276;CD3E mAb – Research Grade
Biosimilar

Obrindatamab Biosimilar – Anti-CD276;CD3E mAb – Research Grade

PX-TA1692 400€
Ifinatamab Biosimilar – Anti-CD276 mAb – Research Grade
Biosimilar

Ifinatamab Biosimilar – Anti-CD276 mAb – Research Grade

PX-TA1847 400€
Vobramitamab Biosimilar – Anti-CD276 mAb – Research Grade
Biosimilar

Vobramitamab Biosimilar – Anti-CD276 mAb – Research Grade

PX-TA1890 400€
Human CD276 (Mab 8H9) Monoclonal Antibody
Monoclonal Antibody

Human CD276 (Mab 8H9) Monoclonal Antibody

FHJ04020 330€

Cart (0 Items)

Your cart is currently empty.

View Products